Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Kuroiwa acquired his Ph.D. in molecular genetics from Tokyo Institute of Technology, Japan, studying genomic imprinting in mammals. Right after his
Ph.D. work, he joined KIRIN Brewery, CO. LTD., to develop its original chromosome engineering technology and contributed to generation of transgenic
mice producing human antibodies for human therapy. This achievement was highly recognized and he moved to US to join Hematech Inc to lead a project
of transgenic cattle producing human polyclonal antibodies to treat a wide variety of human diseases, as a Research Director of Molecular Genetics
department. He established an efficient genetic modification system in cattle and produced the world?s first transchromosomic and knockout cattle. As of
July 1st in 2009, he became a Chief Scientific Officer (CSO) of Research division in Hematech.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals